The panel will present each case and the audience will have an opportunity to ask questions about each case. The learning objectives of the course is an appreciation of the contribution of genetic results for planning treatment, prognostic indicators, assessing future cancer risk and planning long term cancer surveillance for the patient as well as understanding the relevance of genetic testing for patients’ relatives. The course will cover colorectal cancer, breast cancer and endocrine cancer cases. This study day will use interactive learning to explore the advances which make mainstreaming cancer gene testing possible and the challenges and potential processes to its implementation. It will be of interest to all geneticists, genetic counsellors, oncologists, oncology nurses and other healthcare professionals with an interest in cancer genetics.
Venue: The Royal Marsden Conference Centre, London, UK